Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in Adolescence

Keyphrases

• During Pregnancy 100%
• Neurodevelopment 100%
• Opioid Exposure 100%
• Maternal Opioid Use 100%
• Opioid Use 66%
• Neurodevelopmental 66%
• Opioid Use Disorder 66%
• Mouse Model 33%
• Opioids 33%
• Pregnant Women 33%
• Neurological Deficit 33%
• Buprenorphine 33%
• Clinical Presentation 33%
• Hyperactivity 33%
• Causal Relationship 33%
• Dopaminergic Neurons 33%
• Adult Offspring 33%
• Caregiving 33%
• Fetal Brain Development 33%
• Oral Administration 33%
• Female Mice 33%
• Pregnancy Confirmation 33%
• Behavioral Abnormalities 33%
• Maternal Care 33%
• Ventral Tegmental Area 33%
• Neonatal Abstinence Syndrome 33%
• Medication Management 33%
• Late Adolescence 33%
• Cortical Thickness 33%
• Teratogenic Effects 33%
• Oxycodone 33%
• Ventriculomegaly 33%
• Opioid Management 33%
• Corticogenesis 33%
• Giving Behavior 33%
• Prenatal Opioid Exposure 33%
• Fetal Neurodevelopment 33%
• Critical Changes 33%
• Prenatal Opioids 33%

Medicine and Dentistry

• Opiate 100%
• Nerve Cell Differentiation 100%
• Opioid Abuse 20%
• Progeny 20%
• Prevalence 10%
• Drug Therapy 10%
• Withdrawal Syndrome 10%
• Oral Drug Administration 10%
• Maternal Care 10%
• Teratogenesis 10%
• Buprenorphine 10%
• Ventral Tegmental Area 10%
• Hyperactivity 10%
• Dopaminergic Neuron 10%
• Oxycodone 10%
• Ventriculomegaly 10%
• Brain Development 10%
• Corticogenesis 10%
• Adolescence 10%

Neuroscience

• Opiate 100%
• Nerve Cell Differentiation 100%
• Opioid Abuse 20%
• Behavior (Neuroscience) 10%
• Hyperactivity 10%
• Withdrawal Syndrome 10%
• Buprenorphine 10%
• Brain Development 10%
• Ventral Tegmental Area 10%
• Dopaminergic Neuron 10%
• Oxycodone 10%
• Corticogenesis 10%